Detalles de la búsqueda
1.
Predicting Method for the Human Plasma Concentration-Time Profile of a Monoclonal Antibody from the Half-life of Non-human Primates.
Biol Pharm Bull
; 43(5): 823-830, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32378559
2.
Inhibitory FcγRIIb-Mediated Soluble Antigen Clearance from Plasma by a pH-Dependent Antigen-Binding Antibody and Its Enhancement by Fc Engineering.
J Immunol
; 195(7): 3198-205, 2015 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26320252
3.
Complement Activation by an Anti-Dengue/Zika Antibody with Impaired Fcγ Receptor Binding Provides Strong Efficacy and Abrogates Risk of Antibody-Dependent Enhancement.
Antibodies (Basel)
; 12(2)2023 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37218902
4.
Elimination of plasma soluble antigen in cynomolgus monkeys by combining pH-dependent antigen binding and novel Fc engineering.
MAbs
; 14(1): 2068213, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35482905
5.
Comprehensive engineering of a therapeutic neutralizing antibody targeting SARS-CoV-2 spike protein to neutralize escape variants.
MAbs
; 14(1): 2040350, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35293276
6.
High-performance liquid chromatographic assay for the determination of nilotinib in human plasma.
Biol Pharm Bull
; 34(7): 1126-8, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21720025
7.
Association of SLCO1B3 polymorphism with intracellular accumulation of imatinib in leukocytes in patients with chronic myeloid leukemia.
Biol Pharm Bull
; 34(1): 114-9, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21212528
8.
Contribution of BCR-ABL-independent activation of ERK1/2 to acquired imatinib resistance in K562 chronic myeloid leukemia cells.
Cancer Sci
; 101(1): 137-42, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19843070
9.
Exploitation of Elevated Extracellular ATP to Specifically Direct Antibody to Tumor Microenvironment.
Cell Rep
; 33(12): 108542, 2020 12 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33357423
10.
Identification of human IgG1 variant with enhanced FcRn binding and without increased binding to rheumatoid factor autoantibody.
MAbs
; 9(5): 844-853, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28387635
11.
Long lasting neutralization of C5 by SKY59, a novel recycling antibody, is a potential therapy for complement-mediated diseases.
Sci Rep
; 7(1): 1080, 2017 04 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-28439081
12.
Relationship between an effective dose of imatinib, body surface area, and trough drug levels in patients with chronic myeloid leukemia.
Int J Hematol
; 89(5): 642-8, 2009 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-19396513
Resultados
1 -
12
de 12
1
Próxima >
>>